NCT03036878View on ClinicalTrials.gov

ReNu™ Marrow Stimulation Augmentation

NATerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

February 7, 2017

Primary Completion Date

December 6, 2019

Study Completion Date

December 6, 2019

Conditions

Osteochondral Defect

Interventions

OTHER

ReNu

ReNu is an allograft tissue composed of particularized amniotic membrane and cell from the amniotic fluid.

Trial Locations (2)

10021

Hospital for Special Surgery, New York

46143

Orthoindy, Indianapolis

Sponsors

Lead Sponsor

NuTech Medical, Inc

Collaborators (1)

All Listed Sponsors

collaborator

Organogenesis

INDUSTRY

lead

NuTech Medical, Inc

INDUSTRY

NCT03036878 - ReNu™ Marrow Stimulation Augmentation | Biotech Hunter | Biotech Hunter